Reported Tuberculosis in the United States, 2010
(PDF - 254k)
Table 12. Percentages of Tuberculosis Cases by Initial Drug Regimen, Use of Directly Observed Therapy (DOT), and Completion of Therapy (COT): United States, 1993–2010
| Year | Initial Drug Regimen1,2 | Directly Observed Therapy3 | Therapy ≤1 Year Indicated4 | ||||
|---|---|---|---|---|---|---|---|
| I R | IRZ | IRZE | DOT Only | Both DOT and Self-Administered | COT ≤1 Year | COT | |
|
1993 |
(12.9) |
(31.2) |
(40.3) |
(21.7) |
(14.4) |
(64.0) |
(87.4) |
|
1994 |
(7.0) |
(23.3) |
(55.7) |
(28.1) |
(20.5) |
(69.0) |
(87.9) |
|
1995 |
(5.2) |
(20.3) |
(62.7) |
(37.3) |
(21.5) |
(74.0) |
(89.8) |
|
1996 |
(4.2) |
(17.5) |
(67.3) |
(42.5) |
(22.4) |
(76.5) |
(90.6) |
|
1997 |
(3.2) |
(15.1) |
(71.9) |
(47.0) |
(23.8) |
(78.3) |
(91.4) |
|
1998 |
(2.6) |
(12.9) |
(74.3) |
(47.7) |
(26.6) |
(80.7) |
(92.5) |
|
1999 |
(2.2) |
(11.2) |
(76.9) |
(49.4) |
(27.6) |
(80.9) |
(92.4) |
|
2000 |
(2.0) |
(10.4) |
(78.5) |
(52.5) |
(25.8) |
(81.6) |
(92.7) |
|
2001 |
(1.7) |
(9.6) |
(79.8) |
(53.6) |
(27.5) |
(81.8) |
(92.8) |
|
2002 |
(1.8) |
(8.9) |
(80.3) |
(55.4) |
(27.8) |
(82.4) |
(92.7) |
|
2003 |
(1.4) |
(8.1) |
(81.3) |
(56.5) |
(28.5) |
(83.0) |
(92.9) |
|
2004 |
(1.5) |
(6.4) |
(82.4) |
(58.9) |
(27.7) |
(83.7) |
(92.7) |
|
2005 |
(1.3) |
(5.5) |
(83.7) |
(57.9) |
(29.6) |
(83.2) |
(92.5) |
|
2006 |
(1.2) |
(4.8) |
(83.2) |
(57.5) |
(30.4) |
(83.9) |
(93.0) |
|
2007 |
(1.1) |
(4.6) |
(83.5) |
(56.3) |
(32.9) |
(84.5) |
(93.6) |
|
2008 |
(1.0) |
(3.5) |
(84.1) |
(56.5) |
(33.4) |
(84.6) |
(92.7) |
|
2009 |
(1.0) |
(3.1) |
(84.6) |
… |
… |
… |
… |
|
2010 |
(0.8) |
(2.9) |
(84.2) |
… |
… |
… |
… |
1Includes persons alive at diagnosis.
2I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol. Excludes cases with no information on initial drug regimen; 1.00% received no initial drug therapy, 0.14% were started on one drug, and 10.96% had an initial multidrug regimen other than IR, IRZ, or IRZE.
3Includes persons alive at diagnosis with initial drug regimen of one or more drugs prescribed.
4Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy. Excludes persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture.
Note: Data for all years updated through July 21, 2011.
See Technical Notes for description of COT calculation.
